Qilian International Holding Group is a holding company. Through its subsidiaries, Co. is a pharmaceutical and chemical company based in the People's Republic of China that focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers. Co.'s products include Gan Di Xin®, Qilian Shan® Licorice Extract, Qilian Shan® Oxytetracycline Tablets, Qilian Shan® Oxytetracycline Active Pharmaceutical Ingredients, Ahan® antibacterial paste, Heparin Sodium Preparation, Xiongguan® Organic Fertilizer, and Xiongguan® Organic-Inorganic Compound Fertilizer. The QLI stock yearly return is shown above.
The yearly return on the QLI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the QLI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|